Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up, Nancy G. Klimas, J. D. Lundgren, A. Babiker, W. El-Sadr, S. Emery, B. Grund, J. D. Neaton, J. Neuhaus, A. Phillips
Faculty Articles

Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial, Nancy G. Klimas, W. M. El-Sadr, B. Grund, J. Neuhaus, A. Babiker, C. J. Cohen, J. Darbyshire, S. Emery, J. D. Lundgren, A. Phillips, J. D. Neaton
Faculty Articles

Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count>or=300 cells/microL who were assigned to 7.5 MIU interleukin-2, Z. Fox, F. Antunes, R. Davey, B. Gazzard, Nancy G. Klimas, A. Labriola, M. Losso, J. D. Neaton, A. N. Phillips, K. Ruxrungtham, S. Staszewski, L. Weiss, J. D. Lundgren
Faculty Articles